UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

The principal results of the International Immune Tolerance Study: a randomized dose comparison

Blood, 2012-02, Vol.119 (6), p.1335-1344

2012

Volltextzugriff (PDF)

Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO

British journal of haematology, 2013-09, Vol.162 (6), p.758-773

2013

Volltextzugriff (PDF)

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation

British journal of haematology, 2006-06, Vol.133 (6), p.591-605

2006

Volltextzugriff (PDF)

General Surgery in Patients With a Bleeding Diathesis: How We Do It

World journal of surgery, 2011-12, Vol.35 (12), p.2603-2610

2011

Volltextzugriff (PDF)

Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-05, Vol.29 (3), p.743-752

2023

Volltextzugriff (PDF)

A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3

Blood, 2009-07, Vol.114 (5), p.1091-1098

2009

Volltextzugriff (PDF)

Mortality in congenital hemophilia A – a systematic literature review

Journal of thrombosis and haemostasis, 2021-01, Vol.19 (S1), p.6-20

2021

Volltextzugriff (PDF)

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-05, Vol.25 (3), p.398-407

2019

Volltextzugriff (PDF)

Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder

British journal of haematology, 2004-10, Vol.127 (2), p.209-213

2004

Volltextzugriff (PDF)

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

Blood, 2014-11, Vol.124 (23), p.3389-3397

2014

Volltextzugriff (PDF)

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation

Blood, 2007-03, Vol.109 (5), p.1870-1877

2007

Volltextzugriff (PDF)

Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency

Blood, 2015-07, Vol.126 (3), p.397-405

2015

Volltextzugriff (PDF)

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Blood, 2007-08, Vol.110 (3), p.815-825

2007

Volltextzugriff (PDF)

Emicizumab in Hemophilia A

The New England journal of medicine, 2020-02, Vol.382 (8), p.785-786

2020

Volltextzugriff (PDF)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database

Journal of thrombosis and haemostasis, 2021-01, Vol.19 (S1), p.32-41

2021

Volltextzugriff (PDF)

Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.106-115

2024

Volltextzugriff (PDF)

The use of fondaparinux in pregnancy

British journal of haematology, 2015-03, Vol.168 (5), p.762-764

2015

Volltextzugriff (PDF)

Management of pregnancy in type 3 von Willebrand disease with alloantibodies

British journal of haematology, 2018-08, Vol.182 (3), p.440-442

2018

Volltextzugriff (PDF)

The importance of tissue factor source in the management of Factor VII deficiency

Thrombosis and haemostasis, 2007-01, Vol.97 (1), p.151

2007

Volltextzugriff (PDF)

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database

Journal of thrombosis and haemostasis, 2021-01, Vol.19 (S1), p.21-31

2021

Volltextzugriff (PDF)

Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment

Liver international, 2017-08, Vol.37 (8), p.1249-1250

2017

Volltextzugriff (PDF)

Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review

Blood coagulation & fibrinolysis, 2019-10, Vol.30 (7), p.309

2019

Volltextzugriff (PDF)

Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.966-974

2020

Volltextzugriff (PDF)

Inhibitors in nonsevere haemophilia A: outcome and eradication strategies

Thrombosis and haemostasis, 2015-07, Vol.114 (1), p.46

2015

Volltextzugriff (PDF)

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

Expert opinion on biological therapy, 2009-03, Vol.9 (3), p.273-283

2009

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The principal results of the International Immune Tolerance Study: a randomized dose comparison

Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation

General Surgery in Patients With a Bleeding Diathesis: How We Do It

Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)

A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3

Mortality in congenital hemophilia A – a systematic literature review

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation

Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV

Emicizumab in Hemophilia A

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database

Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry

The use of fondaparinux in pregnancy

Management of pregnancy in type 3 von Willebrand disease with alloantibodies

The importance of tissue factor source in the management of Factor VII deficiency

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database

Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment

Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors: a systematic literature review

Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company

Inhibitors in nonsevere haemophilia A: outcome and eradication strategies

Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A

Suchergebnisse filtern